Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D Preisler

Showing results (151-160 of 271) with videos related to

Pageof 28
Sort By:
The International Journal of Artificial Organs|December 1, 1993
CD34+ cell selection: focus on immunomagnetic beads and chymopapainF Silvestri, S Banavali, C Savignano, et al.
Cancer Research|February 1, 1987
Expression of the protooncogenes c-myc, c-fos, and c-fms in acute myelocytic leukemia at diagnosis and in remissionH D Preisler, A J Kinniburgh, G Wei-Dong, et al.
Acta Haematologica|January 1, 1987
Proliferative characteristics of acute nonlymphocytic leukemia in vivoA Raza, Y Maheshwari, K Ucar, et al.
Cancer Genetics and Cytogenetics|May 1, 1989
Involvement of bands 9q21-q22 in five cases of acute nonlymphocytic leukemiaC Sreekantaiah, M R Baer, H D Preisler, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1984
Ph1-positive acute leukemiaA Raza, J Minowada, M Barcos, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1996
Enzymatic programming of apoptotic cell deathS D Mundle, S A Gregory, H D Preisler, et al.
Cell Biochemistry and Function|April 1, 1985
Utility and sensitivity of anti BrdU antibodies in assessing S-phase cells compared to autoradiographyA Raza, K Ucar, R Bhayana, et al.
Cytometry|September 1, 1985
Differences between labeling index and DNA histograms in assessing S-phase cells from a homogeneous group of chronic phase CML patientsA Raza, R Bhayana, K Ucar, et al.
Cancer Treatment Reports|February 1, 1985
Clinical evidence of a cumulative effect of high-dose cytarabine on the cerebellum in patients with acute leukemia: a leukemia intergroup reportA Benger, G P Browman, I R Walker, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
A phase I and pharmacokinetic study of CBT-1 as a multidrug resistance modulator in the treatment of patients with advanced cancerR K Oldham, W K Reid, H D Preisler, et al.
Pageof 28

Showing results (151-160 of 271) with videos related to

Sort By:
Pageof 28
The International Journal of Artificial Organs|December 1, 1993
CD34+ cell selection: focus on immunomagnetic beads and chymopapainF Silvestri, S Banavali, C Savignano, et al.
Cancer Research|February 1, 1987
Expression of the protooncogenes c-myc, c-fos, and c-fms in acute myelocytic leukemia at diagnosis and in remissionH D Preisler, A J Kinniburgh, G Wei-Dong, et al.
Acta Haematologica|January 1, 1987
Proliferative characteristics of acute nonlymphocytic leukemia in vivoA Raza, Y Maheshwari, K Ucar, et al.
Cancer Genetics and Cytogenetics|May 1, 1989
Involvement of bands 9q21-q22 in five cases of acute nonlymphocytic leukemiaC Sreekantaiah, M R Baer, H D Preisler, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1984
Ph1-positive acute leukemiaA Raza, J Minowada, M Barcos, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1996
Enzymatic programming of apoptotic cell deathS D Mundle, S A Gregory, H D Preisler, et al.
Cell Biochemistry and Function|April 1, 1985
Utility and sensitivity of anti BrdU antibodies in assessing S-phase cells compared to autoradiographyA Raza, K Ucar, R Bhayana, et al.
Cytometry|September 1, 1985
Differences between labeling index and DNA histograms in assessing S-phase cells from a homogeneous group of chronic phase CML patientsA Raza, R Bhayana, K Ucar, et al.
Cancer Treatment Reports|February 1, 1985
Clinical evidence of a cumulative effect of high-dose cytarabine on the cerebellum in patients with acute leukemia: a leukemia intergroup reportA Benger, G P Browman, I R Walker, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
A phase I and pharmacokinetic study of CBT-1 as a multidrug resistance modulator in the treatment of patients with advanced cancerR K Oldham, W K Reid, H D Preisler, et al.
Pageof 28